The iodine can make someone feel better, but it is actually wearing out the thyroid gland, causing more immune destruction to the thyroid gland
Int J Immunopathol Pharmacol (2016) 29:38697
In the SURMOUNT-1 trial, tirzepatide produced average body-weight losses of 15.0% at 5 mg, 19.5% at 10 mg, and 22.5% at 15 mg over 72 weeks, compared with 3.1% for placebo (Jastreboff et al., NEJM 2022)
NAC improves hepatic glutathione levels, reduces oxidative stress, improves insulin sensitivity, and supports detoxificationmaking it highly relevant in NAFLD/NASH management
Others add glycine for its potential synergistic effects on metabolic health
Sign up to be notified when SLU-PP-332 is available and receive early access to this breakthrough therapy